Charles Schwab Investment Management Inc. Purchases 33,844 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Charles Schwab Investment Management Inc. raised its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 5.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 636,020 shares of the company's stock after acquiring an additional 33,844 shares during the quarter. Charles Schwab Investment Management Inc. owned 1.29% of Prestige Consumer Healthcare worth $49,667,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in the stock. Allspring Global Investments Holdings LLC increased its holdings in shares of Prestige Consumer Healthcare by 3.1% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company's stock valued at $126,274,000 after purchasing an additional 49,331 shares in the last quarter. Geode Capital Management LLC increased its holdings in Prestige Consumer Healthcare by 4.0% in the third quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company's stock valued at $95,678,000 after buying an additional 50,961 shares in the last quarter. Congress Asset Management Co. lifted its position in shares of Prestige Consumer Healthcare by 5.0% during the 4th quarter. Congress Asset Management Co. now owns 908,742 shares of the company's stock valued at $70,964,000 after acquiring an additional 43,619 shares during the period. Boston Trust Walden Corp lifted its holdings in shares of Prestige Consumer Healthcare by 43.5% in the fourth quarter. Boston Trust Walden Corp now owns 831,627 shares of the company's stock valued at $64,942,000 after purchasing an additional 252,089 shares in the last quarter. Finally, Eagle Asset Management Inc. boosted its stake in shares of Prestige Consumer Healthcare by 0.7% during the 3rd quarter. Eagle Asset Management Inc. now owns 434,514 shares of the company's stock worth $31,328,000 after purchasing an additional 3,227 shares during the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Canaccord Genuity Group boosted their target price on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Raymond James upgraded shares of Prestige Consumer Healthcare to a "moderate buy" rating in a research report on Thursday, December 19th. Sidoti lowered Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 price objective for the company. in a research report on Monday, December 9th. Oppenheimer increased their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research report on Thursday, February 13th. Finally, StockNews.com downgraded shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Monday, March 10th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $92.60.

Insider Activity

In related news, SVP Mary Beth Fritz sold 1,678 shares of the business's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the sale, the senior vice president now owns 17,157 shares of the company's stock, valued at $1,544,130. The trade was a 8.91 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Stock Performance

Shares of PBH stock traded up $1.18 during mid-day trading on Monday, reaching $84.87. The stock had a trading volume of 321,552 shares, compared to its average volume of 258,725. The firm has a market cap of $4.20 billion, a PE ratio of 19.88, a P/E/G ratio of 2.69 and a beta of 0.46. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $90.04. The firm's 50 day simple moving average is $81.47 and its 200 day simple moving average is $78.31.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, beating analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.